IDEAYA Biosciences (IDYA) Other Accumulated Expenses (2018 - 2026)
IDEAYA Biosciences (IDYA) reported Other Accumulated Expenses of $54.44 million for Q3 2026, up 65.6% from $32.88 million a year earlier and up 43.4% from the prior quarter.
Powered by 
Analysis
IDEAYA Biosciences (IDYA) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
At the end of FY2025, IDEAYA Biosciences posted Other Accumulated Expenses of $26.51 million, up 32.8% from FY2024.
- Other Accumulated Expenses has a five-year compound annual growth rate of 38.2% (FY2020 to FY2025).
- By year, Other Accumulated Expenses came in at $19.96 million in FY2024 (+86.9%), $10.68 million in FY2023 (-4.2%), $11.15 million in FY2022 (+41.7%) and $7.86 million in FY2021 (+49.5%).
- The Q3 2026 figure ranks as the highest quarterly Other Accumulated Expenses in data going back to Q4 2018.
- Year over year, Other Accumulated Expenses has now increased in each of the last ten quarters, with growth averaging 61.9% over the last eight quarters.
- The high point for year-over-year Other Accumulated Expenses in five years was Q1 2025 (growth of 112.6%); the low point was Q2 2023 (a decline of 24.4%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $37.98 million (Q2 2026), $33.09 million (Q1 2026) and $26.51 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | IDEAYA Biosciences | 3.07 Bn | 90.55 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 54.44 Mn |
| Jun 30, 2026 | 37.98 Mn |
| Mar 31, 2026 | 33.09 Mn |
| Dec 31, 2025 | 26.51 Mn |
| Sep 30, 2025 | 32.88 Mn |
| Jun 30, 2025 | 28.12 Mn |
| Mar 31, 2025 | 25.98 Mn |
| Dec 31, 2024 | 19.96 Mn |
| Sep 30, 2024 | 19.03 Mn |
| Jun 30, 2024 | 17.37 Mn |
| Mar 31, 2024 | 12.22 Mn |
| Dec 31, 2023 | 10.68 Mn |
| Sep 30, 2023 | 9.23 Mn |
| Jun 30, 2023 | 8.48 Mn |
| Mar 31, 2023 | 12.55 Mn |
| Dec 31, 2022 | 11.15 Mn |
| Sep 30, 2022 | 11.20 Mn |
| Jun 30, 2022 | 11.22 Mn |
| Mar 31, 2022 | 9.16 Mn |
| Dec 31, 2021 | 7.86 Mn |
API Access
IDEAYA Biosciences Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IDYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "IDYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=IDYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();